STATE OF WISCONSIN INVESTMENT BOARD - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 145 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,977,708
+3.0%
43,003
+28.7%
0.01%
+20.0%
Q2 2023$1,920,015
+45.3%
33,409
-5.2%
0.01%
+25.0%
Q1 2023$1,321,463
+20.0%
35,239
-10.3%
0.00%0.0%
Q4 2022$1,100,934
+0.3%
39,291
+0.5%
0.00%
+33.3%
Q3 2022$1,098,000
-24.1%
39,081
-6.0%
0.00%
-25.0%
Q2 2022$1,446,000
-20.4%
41,568
-17.8%
0.00%0.0%
Q1 2022$1,817,000
+54.2%
50,6000.0%0.00%
+100.0%
Q4 2021$1,178,000
+22.5%
50,6000.0%0.00%0.0%
Q3 2021$962,000
-5.7%
50,6000.0%0.00%0.0%
Q2 2021$1,020,000
+10.0%
50,6000.0%0.00%0.0%
Q1 2021$927,000
-8.9%
50,6000.0%0.00%0.0%
Q4 2020$1,018,000
-4.6%
50,600
-11.1%
0.00%
-33.3%
Q3 2020$1,067,000
-16.5%
56,9000.0%0.00%
-25.0%
Q2 2020$1,278,000
+55.7%
56,900
+2.9%
0.00%
+33.3%
Q1 2020$821,000
-20.9%
55,300
+2.8%
0.00%0.0%
Q4 2019$1,038,000
-2.7%
53,8000.0%0.00%0.0%
Q3 2019$1,067,000
-0.9%
53,800
+5.5%
0.00%0.0%
Q2 2019$1,077,000
+10.2%
51,000
+6.7%
0.00%0.0%
Q1 2019$977,000
+33.1%
47,800
+29.5%
0.00%
+50.0%
Q4 2018$734,000
+5.5%
36,900
+1.9%
0.00%0.0%
Q3 2018$696,000
+26.1%
36,2000.0%0.00%0.0%
Q2 2018$552,000
+5.1%
36,200
+29.3%
0.00%0.0%
Q1 2018$525,000
-2.6%
28,0000.0%0.00%
+100.0%
Q4 2017$539,000
+7.8%
28,0000.0%0.00%0.0%
Q3 2017$500,0000.0%28,0000.0%0.00%
-50.0%
Q2 2017$500,00028,0000.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2021
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders